Virág László

1.

Sturniolo, I., Váróczy, C., Regdon, Z., Türk-Mázló, A., Muzsai, S., Bácsi, A., Intili, G., Hegedűs, C., Boothby, M. R., Holechek, J., Ferraris, D., Schüler, H., Virág, L.: PARP14 contributes to the development of the tumor-associated macrophage phenotype.
Int. J. Mol. Sci. 25 (7), 1-21, (article identifier: 3601), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis (2023)

Q1 Computer Science Applications (2023)

D1 Inorganic Chemistry (2023)

Q1 Medicine (miscellaneous) (2023)

Q2 Molecular Biology (2023)

D1 Organic Chemistry (2023)

Q1 Physical and Theoretical Chemistry (2023)

D1 Spectroscopy (2023)

2.

Oit-Wiscombe, I., Virág, L., Kilk, K., Soomets, U., Altraja, A.: Pattern of Expression of Genes Involved in Systemic Inflammation and Glutathione Metabolism Reveals Exacerbation of COPD.
Antioxidants. 13 (8), 1-14, (article identifier: 953), 2024.

doi DEA

Journal metrics:

Q1 Biochemistry (2023)

Q2 Cell Biology (2023)

Q1 Clinical Biochemistry (2023)

D1 Food Science (2023)

Q2 Molecular Biology (2023)

Q1 Physiology (2023)

3.

Sturniolo, I., Váróczy, C., Bede, Á. M., Hegedűs, C., Demény, M. Á., Virág, L.: Quantifying antibody-dependent cellular cytotoxicity in a tumor spheroid model: application for drug discovery.
J. Vis. Exp. 206, 1-14, (article identifier: 65922), 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)

Q2 Chemical Engineering (miscellaneous) (2023)

Q3 Immunology and Microbiology (miscellaneous) (2023)

Q3 Neuroscience (miscellaneous) (2023)

4.

Skopál, A., Ujlaki, G., Gerencsér, A. T., Bankó, C., Bacsó, Z., Ciruela, F., Virág, L., Haskó, G., Kókai, E.: Adenosine A2A Receptor Activation Regulates Niemann-Pick C1 Expression and Localization in Macrophages.
Curr. Issues Mol. Biol. 45 (6), 4948-4969, 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Microbiology

Q2 Microbiology (medical)

Q3 Molecular Biology

5.

Guti, E., Bede, Á. M., Váróczy, C., Hegedűs, C., Demény, M. Á., Virág, L.: High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds.
JoVE. 198, 1-12, (article identifier: 64485), 2023.

doi DEA WoS Scopus

Journal metrics:

Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Chemical Engineering (miscellaneous)

Q3 Immunology and Microbiology (miscellaneous)

Q3 Neuroscience (miscellaneous)

6.

Virág, L.: 100 éves a Debreceni Egyetem Orvosi Vegytani Intézete.
Gerundium. 8 (1-2), 203-216, 2022.

doi DEA

7.

Skopál, A., Kéki, T., Tóth, P. Á., Csóka, B., Koscsó, B., Németh, Z. H., Antonioli, L., Ivessa, A., Ciruela, F., Virág, L., Haskó, G., Kókai, E.: Cathepsin D interacts with adenosine A2A receptors in mouse macrophages to modulate cell surface localization and inflammatory signaling.
J. Biol. Chem. 298 (5), 1-18, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

Q1 Molecular Biology

8.

Hajnády, Z., Nagy-Pénzes, M., Demény, M. Á., Kovács, K., El-Hamoly, T., Maléth, J., Hegyi, P. J., Polgár, Z., Hegedűs, C., Virág, L.: OGG1 Inhibition Reduces Acinar Cell Injury in a Mouse Model of Acute Pancreatitis.
Biomedicines. 10 (10), 1-17, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

9.

Guti, E., Regdon, Z., Sturniolo, I., Kiss, A., Kovács, K., Demény, M. Á., Szöőr, Á., Vereb, G., Szöllősi, J., Hegedűs, C., Polgár, Z., Virág, L.: The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Cancer Research

Q1 Immunology

Q1 Immunology and Allergy

D1 Medicine (miscellaneous)

Q1 Oncology

10.

Nagy-Pénzes, M., Hajnády, Z., Regdon, Z., Demény, M. Á., Kovács, K., El-Hamoly, T., Maléth, J., Hegyi, P. J., Hegedűs, C., Virág, L.: Tricetin Reduces Inflammation and Acinar Cell Injury in Cerulein-Induced Acute Pancreatitis: the Role of Oxidative Stress-Induced DNA Damage Signaling.
Biomedicines. 10 (6), 1-20, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

11.

Torma, F., Bakonyi, P., Regdon, Z., Gombos, Z., Jókai, M., Babszki, G., Fridvalszki, M., Virág, L., Naito, H., Iftikhar Bukhari, S., Radák, Z.: Blood flow restriction during the resting periods of high-intensity resistance training does not alter performance but decreases MIR-1 and MIR-133A levels in human skeletal muscle.
Sports Medicine and Health Science. 3 (1), 40-45, 2021.

doi DEA

12.

Molnár, T., Pallagi, P., Tél, B., Király, R., Csoma, E., Jenei, V., Varga, Z., Gogolák, P., Odile Hueber, A., Máté, Z., Erdélyi, F., Szabó, G., Pettkó-Szandtner, A., Bácsi, A., Virág, L., Maléth, J., Koncz, G.: Caspase-9 acts as a regulator of necroptotic cell death.
FEBS J. 288 (22), 6476-6491, 2021.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

Q1 Molecular Biology

13.

Regdon, Z., Demény, M. Á., Kovács, K., Hajnády, Z., Nagy-Pénzes, M., Bakondi, E., Kiss, A., Hegedűs, C., Virág, L.: High-Content Screening identifies inhibitors of oxidative stress-induced parthanatos: cytoprotective and anti-inflammatory effects of ciclopirox.
Br. J. Pharmacol. 178 (5), 1095-1113, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmacology

14.

Horváth, B., Khan, M. N., Hézső, T., Dienes, C., Kovács, Z. M., Kiss, D. Z., Prorok, J., Árpádffy-Lovas, T., Varga, R., Fujii, E., Topal, L., Kistamás, K., Varró, A., Virág, L.: Is selective late sodium current inhibition different from class I/B antiarrhythmic action? Comparison of the effects of GS967 to mexiletine in canine ventricular myocardium.
Europace. 23 (Supplement), iii622, 2021.

doi DEA

15.

Kiss, A., Csikos, C., Regdon, Z., Polgár, Z., Virág, L., Hegedűs, C.: NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.
Int. J. Mol. Sci. 22 (16), 1-17, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

16.

El-Hamoly, T., Hajnády, Z., Nagy-Pénzes, M., Bakondi, E., Regdon, Z., Demény, M. Á., Kovács, K., Hegedűs, C., Abd El-Rahman, S. S., Szabó, É., Maléth, J., Hegyi, P. J., Virág, L.: Poly(ADP-Ribose) Polymerase 1 Promotes Inflammation and Fibrosis in a Mouse Model of Chronic Pancreatitis.
Int. J. Mol. Sci. 22 (7), 1-15, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

17.

Demény, M. Á., Virág, L.: The PARP enzyme family and the hallmarks of cancer. Part 1. Cell intrinsic hallmarks.
Cancers (Basel). 13, 1-28, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

18.

Demény, M. Á., Virág, L.: The PARP enzyme family and the hallmarks of cancer. Part 2. Hallmarks related to cancer host interactions.
Cancers (Basel). 13, 1-21, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

19.

Lontay, B., Kiss, A., Virág, L., Tar, K.: How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.
Int. J. Mol. Sci. 21 (12), 1-34, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

D1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

D1 Physical and Theoretical Chemistry

D1 Spectroscopy

20.

Kiss, B. K., Szántó, M., Hegedűs, C., Antal, D., Szödényi, A., Márton, J., Méhes, G., Virág, L., Szegedi, A., Bai, P.: Poly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis.
Exp. Dermatol. 29 (1), 79-85, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Dermatology

Q2 Molecular Biology

21.

Kiss, A., Ráduly, A. P., Regdon, Z., Polgár, Z., Tarapcsák, S., Sturniolo, I., El-Hamoly, T., Virág, L., Hegedűs, C.: Targeting nuclear NAD+ synthesis inhibits DNA repair, impairs metabolic adaptation increases chemosensitivity of U-2OS osteosarcoma cells.
Cancers (Basel). 12 (5), 1-27, 2020.

DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

22.

Douida, A., Batista, F., Robaszkiewicz, A., Botó, P., Aladdin, A., Szenykiv, M., Czinege, R., Virág, L., Tar, K.: The proteasome activator PA200 regulates expression of genes involved in cell survival upon selective mitochondrial inhibition in neuroblastoma cells.
J. Cell. Mol. Med. 24 (12), 6716-6730, 2020.

doi DEA

Journal metrics:

Q2 Cell Biology

Q1 Molecular Medicine

23.

Kovács, P., Csonka, T., Kovács, T., Sári, Z., Ujlaki, G., Sipos, A., Karányi, Z., Szeőcs, D., Hegedűs, C., Uray, K., Jankó, L., Kiss, M., Kiss, B. K., Laoui, D., Virág, L., Méhes, G., Bai, P., Mikó, E.: Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer.
Cancers (Basel). 11, 1-31, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Cancer Research

Q1 Oncology

24.

Regdon, Z., Robaszkiewicz, A., Kovács, K., Rygielska, Ż., Hegedűs, C., Bodoor, K., Szabó, É., Virág, L.: LPS protects macrophages from AIF-independent parthanatos by downregulation of PARP1 expression, induction of SOD2 expression, and a metabolic shift to aerobic glycolysis.
Free Radic. Biol. Med. 131, 184-196, 2019.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Physiology (medical)

25.

Tokarz, P., Poszaj, T., Regdon, Z., Virág, L., Robaszkiewicz, A.: PARP1-LSD1 functional interplay controls transcription of SOD2 that protects human pro-inflammatory macrophages from death under an oxidative condition.
Free Radic. Biol. Med. 131, 218-224, 2019.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Physiology (medical)

Publication list